Institute of Radiology, University Medical Center Regensburg, Regensburg, Germany.
Clin Hemorheol Microcirc. 2009;43(1-2):57-69. doi: 10.3233/CH-2009-1221.
Evaluation and characterization of the vascularisation and perfusion of liver tumors by means of image fusion of dynamic contrast-enhanced ultrasound (CEUS), multidetector-CT (MD-CT) or magnetic resonance imaging (MRI) with the ultrasound navigation technique.
For interventional planning a real-time image fusion involving CEUS (LOGIQ E9, GE) was performed in 20 patients (12 men, 8 women, age 43-69 years, median 54) with histologically confirmed malignant liver tumors (9 x hepatocellular carcinoma (HCC), 5 x metastases, 2 x hemangiomas, 1 x cholangiocellular carcinoma (CCC), 1 x lymphoma, 1 x neuroendocrine tumor, 1 x focal nodular hypoplasia (FNH)). In 17 patients the real-time CEUS was fused with contrast-enhanced MD-CT and in three patients with contrast-enhanced MRI (Gd-DTPA and liver-specific contrast medium Resovist. All of the ultrasound examinations were performed by an experienced examiner with a multi-frequency probe (2-5 MHz, LOGIQ E9, GE); dynamic image sequences up to 3 minutes in true agent detection mode of contrast harmonic imaging (CHI) were documented. An evaluation of the tumor was performed by the characterization of the dynamics of the contrast medium and microperfusion with CEUS, fused with MD-CT or MRI.
In 18/20 cases there was an accurate agreement with respect to the segmental localization of the tumor lesion. In 2/20 cases the localization was comparable with the image fusion of CEUS and reference imaging (a total of at least 65 lesions: 3 x 1 lesion, 5 x 2 lesions, 8 x 3 lesions, 2 x 5 lesions, 1 x 8 lesions, 1 x at least 10 lesions (multifocal)). With image fusion a certain characterization was attained in 17/20 cases. In 3/20 cases (lymphoma after liver transplantation, multifocal CCC, metastases of a neuroendocrine tumor) the diagnosis was at first doubtful and had to be confirmed histologically. In patients with HCC an evaluation of the tumor perfusion was feasible in all 9 cases (8/9 after local trans-arterial chemoembolization (TACE), 1/9 after radio frequency ablation (RFA)). A tendency toward the identification of more lesions with image fusion of CEUS and CT than with contrast-enhanced CT alone could be recognized (p=0.059).
Applying a new real-time fusion technique of MD-CT or MRI with CEUS new possibilities for the evaluation, intervention and monitoring of the therapy of liver lesions were made possible, since the method also comprised the dynamic microperfusion.
通过超声导航技术将动态对比增强超声(CEUS)、多排 CT(MD-CT)或磁共振成像(MRI)与实时图像融合,评估和描述肝肿瘤的血管生成和灌注情况。
为了进行介入治疗计划,对 20 名经组织学证实为恶性肝肿瘤的患者(12 名男性,8 名女性,年龄 43-69 岁,中位年龄 54 岁)进行了实时 CEUS 图像融合(LOGIQ E9,GE)。其中 9 例为肝细胞癌(HCC),5 例为转移瘤,2 例为肝血管瘤,1 例为胆管细胞癌(CCC),1 例为淋巴瘤,1 例为神经内分泌肿瘤,1 例为局灶性结节性增生(FNH)。在 17 例患者中,实时 CEUS 与增强 MD-CT 融合,在 3 例患者中与增强 MRI(钆-DTPA 和肝特异性对比剂 Resovist)融合。所有超声检查均由经验丰富的超声医师使用多频探头(2-5 MHz,LOGIQ E9,GE)进行;在对比谐波成像(CHI)的真正造影剂检测模式下记录了长达 3 分钟的动态图像序列。通过对 CEUS 融合的肿瘤动态造影剂和微血管灌注的特征描述来评估肿瘤。
在 20 例患者中,18 例患者的肿瘤病变节段定位与融合图像一致。在 20 例患者中,2 例患者的定位与 CEUS 和参考成像的融合图像具有可比性(总共至少有 65 个病变:3 例 1 个病变,5 例 2 个病变,8 例 3 个病变,2 例 5 个病变,1 例 8 个病变,1 例至少 10 个病变(多灶性))。在 20 例患者中,17 例通过融合图像可获得一定的特征描述。在 3 例患者中(肝移植后淋巴瘤、多灶性 CCC、神经内分泌肿瘤转移),最初的诊断存在疑问,需要进行组织学确认。在 9 例 HCC 患者中,所有患者(8 例经局部经动脉化疗栓塞(TACE)后,1 例经射频消融(RFA)后)的肿瘤灌注评估均可行。通过 CEUS 与 CT 融合,可识别出更多病变的趋势(与单纯增强 CT 相比,p=0.059)。
通过应用 MD-CT 或 MRI 与 CEUS 的新实时融合技术,为肝病变的评估、介入治疗和监测提供了新的可能,因为该方法还包括动态微血管灌注。